Skip to Content

Join the 'Praxbind' group to help and get support from people like you.

Praxbind News

FDA Approves Praxbind (idarucizumab) as a Reversal Agent for the Anticoagulant Pradaxa

Posted 19 Oct 2015 by Drugs.com

October 16, 2015 – The U.S. Food and Drug Administration today granted accelerated approval to Praxbind (idarucizumab) for use in patients who are taking the anticoagulant Pradaxa (dabigatran) during emergency situations when there is a need to reverse Pradaxa’s blood-thinning effects. “The anticoagulant effects of Pradaxa are important and life-saving for some patients, but there are sit ...

FDA Approves Praxbind to Reverse Blood Thinner's Effect

Posted 19 Oct 2015 by Drugs.com

FRIDAY, Oct. 16, 2015 – Emergency use of a drug to reverse the blood-thinning effects of another drug has been approved by the U.S. Food and Drug Administration. Praxbind (idarucizumab) was cleared for use in patients who are taking the anticoagulant Pradaxa (dabigatran) when there is an urgent need to reverse Pradaxa's blood-thinning effects. "The anticoagulant effects of Pradaxa are important ...

Ask a Question

Further Information

Related Condition Support Groups

Reversal of Dabigatran

Praxbind Patient Information at Drugs.com